Contributed by:
Research Grants Supported
Leonardo Cortez, Ph.D., 2018
Isolation and Strain-Specific Characterization of Pathogenic CJD Prion Particles
Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada
Stéphane Haik, M.D., Ph.D., 2017
Worms: A Novel Genetic Model for Therapeutic Research in Prion Disease
Alzheimer’s and Prion Diseases Lab at the Brain & Spine Institute (ICM) of the Salpêtrière Hospital, Sorbonne Université,
Paris, France
Roberto Chiesa, Ph.D., 2016
A New Anti-Prion Compound that Reduces PrPc levels and Inhibits PrPsc Replication
[Awaiting permission to release from Dr. Chiesa.]
Istituto di Ricerche Farmacologiche Mario Negri
Milano, Italy
Julie Moreno, Ph.D., 2015
The Role of Cellular Chaperones and the Unfolded Protein Response in Gerstmann-Sträussler-Scheinker Syndrome
Prion Research Center, Colorado State University
Fort Collins, Colorado
Paula Saa, Ph.D., 2012
In Vitro and In Vivo Modeling of Gerstmann-Sträussler-Scheinker Syndrome (GSS) With Spontaneously Generated Human Recombinant PrPres Harboring the P102L Substitution (P102L-rPrPres)
Biomedical Services, Transmissible Diseases Department
Rockville, Maryland
Gianfranco Puoti, M.D., Ph.D., 2009
Analyses of the Protein Tau to Help Determine Whether the Newly Discovered Protease-Sensitive Prionopathy is the Sporadic Form of Gerstmann-Sträussler-Scheinker Disease (GSS)
The National Prion Disease Pathology Surveillance Center
Cleveland, Ohio